- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02624622
Chlorhexidine Cord Care for Newborn Infants in Kenya
A Comparison Between Mothers and Community Health Workers on Use of Chlorhexidine for Umbilical Cord Care: A Randomized Noninferiority Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87131
- UNM
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: All pregnant women who are 18 years of age or older (based on their stated date of birth) who attend the two selected health care facilities (Kisesini Dispensary and Katangi Health Center) for their prenatal care will be eligible to participate if they reside in one of the villages of the five sublocations of the target region (Kyua, Makusya, Katangi, Mekilingi, Syokisinga) and they plan to deliver within the target region -
Exclusion Criteria: Pregnant women who plan to deliver outside of the target area or plan to be away from the area during the newborn infant's first week of life will be excluded
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: CHW applies chlorhexidine
Intervention: Chlorhexidine gel 7.1% topical 3 gm applied to the umbilical cord stump in one application.
The community health worker is given the chlorhexidine to apply to the umbilical cord stump within 24 hours of delivery of the newborn infant.
|
|
|
Experimental: Mother applies chlorhexidine
Intervention: Chlorhexidine gel 7.1% topical 3 gm applied to the umbilical cord stump in one application.
Mother is given the chlorhexidine during the first prenatal care visit to apply to the umbilical cord stump within 24 hours of delivery of the newborn infant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of infants age 0 to 7 days who develop omphalitis
Time Frame: 7 days after birth
|
Omphalitis is defined as redness of the umbilical stump that extends to the skin of the abdomen with or without purulent exudate (pus).
|
7 days after birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The average time in minutes from birth to chlorhexidine application (total time for all participants in the arm divided by total participants in the arm).
Time Frame: 7 days
|
The duration in minutes from the recorded birth time until the recorded time that chlorhexidine is applied to the umbilical cord stump
|
7 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: ANGELO TOMEDI, MD, University of New Mexico
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNM HRRC 14-356
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Omphalitis
-
Aga Khan UniversityJohn Snow, Inc.Completed
-
Nantes University HospitalTerminated
-
Johns Hopkins Bloomberg School of Public HealthInternational Centre for Diarrhoeal Disease Research, Bangladesh; Government... and other collaboratorsCompletedInfection | OmphalitisBangladesh
-
Boston UniversityBill and Melinda Gates Foundation; Thrasher Research FundCompleted
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; Annamalai University; Ministry of Health and...CompletedOmphalitis | Neonatal Mortality | Cord CareTanzania
-
Makerere UniversityCentre For International HealthCompleted
-
Sheikh Zayed Federal Postgraduate Medical InstituteCompletedOmphalitis | Neonatal SepsisPakistan
-
The Hospital for Sick ChildrenAga Khan University; Aga Khan Health Services; The Aga Khan FoundationActive, not recruitingOmphalitis | Neonatal Mortality | Post-Partum HemorrhagePakistan
-
Yale UniversityUniversity of California, San Diego; Inter-American Development BankCompletedDiarrhea | Hypothermia | Preterm Delivery | Upper Respiratory Infection | OmphalitisUnited States, Honduras
-
Aga Khan UniversityDepartment for International Development, United KingdomCompletedPneumonia | Sepsis | Eclampsia | Respiratory Distress Syndrome | Postpartum Hemorrhage | Omphalitis | Birth Asphyxia | Puerperal SepsisPakistan
Clinical Trials on Chlorhexidine application by CHW
-
Chinese University of Hong KongAsia Diabetes FoundationCompleted
-
George Washington UniversityCompleted
-
Betul Zeynep YildizEnrolling by invitation
-
Centre Hospitalier de Saint-BrieucCompletedEmergencies | Ankle Injuries | Nurse's RoleFrance
-
Hasselt UniversityJessa HospitalCompletedCoronary Artery DiseaseBelgium
-
Yuzuncu Yıl UniversityCompleted
-
WepromSIVAN Innovation LdtCompleted
-
Institut Cancerologie de l'OuestTerminated
-
Riyadh Colleges of Dentistry and PharmacyUnknownDry SocketSaudi Arabia
-
University of PaviaCompleted